Gut Microbiota Changes during Dimethyl Fumarate Treatment in Patients with Multiple Sclerosis

The gut microbiota is involved in the development of the immune system and can modulate the risk for immune-mediated disorders such as multiple sclerosis (MS). Dysbiosis has been demonstrated in MS patients and its restoration by disease-modifying treatments (DMTs) is hypothesized. We aimed to study...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferri, Caterina, Castellazzi, Massimiliano, Merli, Nicola, Laudisi, Michele, Baldin, Elisa, Baldi, Eleonora, Mancabelli, Leonardo, Ventura, Marco, Pugliatti, Maura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917003/
https://www.ncbi.nlm.nih.gov/pubmed/36769041
http://dx.doi.org/10.3390/ijms24032720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917003/
https://www.ncbi.nlm.nih.gov/pubmed/36769041
http://dx.doi.org/10.3390/ijms24032720

Ejemplares similares